HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers

Lulić, Lucija; Jakovčević, Antonia; Kovačić, Iva; Manojlović, Luka; Dediol, Emil; Skelin, Josipa; Tomaić, Vjekoslav (2023) HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers. Pathogens, 12 (8). ISSN 2076-0817

PDF - Published Version - article
Available under License Creative Commons Attribution.
Download (11MB)

Official URL: https://www.mdpi.com/2076-0817/12/8/1013

Abstract

Infection with human papillomaviruses (HPVs), in particular with HPV type 16, is now considered to be a key risk factor for the development of a subset of oropharyngeal squamous cell carcinomas (OPSCC) that show different epidemiological, clinical, and prognostic characteristics from HPV-negative (HPV−) OPSCCs. So far, extensive research efforts aiming to distinguish these two distinct entities have not identified specific biomarkers, nor led to different therapies. Previous research has shown that HPV16 E6 oncoprotein binds NHERF2, inducing its proteasomal degradation, and consequently increasing cell proliferation; we therefore aimed to investigate how this might be reflected in human histological samples. We analyzed NHERF2 expression patterns in HPV16-positive (HPV16+) and HPV− OPSCC samples, to investigate any potential differences in NHERF2 pattern. Interestingly, we observed a statistically significant decrease in NHERF2 levels in HPV16+ and poorly differentiated HPV− OPSCCs, compared with healthy tissue. Furthermore, we observed a significant reduction in the percentage of NHERF2 immunoreactive cancer cells in HPV16+ tumors, compared with well and moderately differentiated HPV− OPSCCs, suggesting the importance of 16E6’s targeting of NHERF2 in HPV-driven oncogenesis in the head and neck area.

Item Type:

Article

Uncontrolled Keywords:

HNSCC; OPSCC; HPV; E6; p16; NHERF2

Subjects:

BIOMEDICINE AND HEALTHCARE > Basic Medical Sciences

Divisions:

Division of Molecular Medicine

Projects: